In The News

In Law360, Tom Bulleit Examines Trump’s Latest Drug Pricing Executive Order

Practices: Health Care, Health Care Finance & Restructuring, Managed Care, Life Sciences

Capital Insights.

In an article published by Law360, health care partner Tom Bulleit (Washington, D.C.) discussed President Trump’s latest drug pricing executive order that seeks to sharply cut drug prices by capping prices of Medicare Part B and Part D drugs.

Tom explained that the executive order, which came right before the U.S. presidential election, would be met with legal challenges that would set up further obstacles to implementation.

Cookie Settings